293 related articles for article (PubMed ID: 15568297)
1. Development and validation of the BSP-BPH (Bononian Satisfaction Profile--Benign Prostatic Hyperplasia) a "disease-specific" questionnaire for the evaluation of health related quality of life in patients with benign prostatic hyperplasia.
Bertaccini A; Martinelli A; Ceccarelli R; Palmieri F; Vitullo G; Urbinati M; Marchiori D; Costal F; Martorana G
Arch Ital Urol Androl; 2004 Sep; 76(3):103-9. PubMed ID: 15568297
[TBL] [Abstract][Full Text] [Related]
2. BSP-PC (Bononian Satisfaction Profile--Prostate Cancer): development and validation of a "disease-specific" questionnaire for the evaluation of health-related quality of life in patients with prostate cancer.
Bertaccini A; Ceccarelli R; Urbinati M; Galassi P; Vitullo G; De Stefano R; Botteghi B; Marchiori D; Martorana G
Arch Ital Urol Androl; 2003 Dec; 75(4):187-94. PubMed ID: 15005491
[TBL] [Abstract][Full Text] [Related]
3. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.
Donovan JL; Kay HE; Peters TJ; Abrams P; Coast J; Matos-Ferreira A; Rentzhog L; Bosch JL; Nordling J; Gajewski JB; Barbalias G; Schick E; Silva MM; Nissenkorn I; de la Rosette JJ
Br J Urol; 1997 Nov; 80(5):712-21. PubMed ID: 9393291
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of self-estimation of disuric disorders gauged IPSS scale and qualities of lives QoL with self-estimation of sexual life gauged by IIEF-5 scale].
Lipczyński W; Dobrowolska-Glazar B; Dobrowolski ZF
Przegl Lek; 2012; 69(6):247-52. PubMed ID: 23094437
[TBL] [Abstract][Full Text] [Related]
6. Scoring the short form ICSmaleSF questionnaire. International Continence Society.
Donovan JL; Peters TJ; Abrams P; Brookes ST; de aa Rosette JJ; Schäfer W
J Urol; 2000 Dec; 164(6):1948-55. PubMed ID: 11061889
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a quality-of-life scale for Chinese patients with benign prostatic hyperplasia.
Shi J; Sun Z; Cai T; Yang L
BJU Int; 2004 Oct; 94(6):837-44. PubMed ID: 15476519
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK.
Trueman P; Hood SC; Nayak US; Mrazek MF
BJU Int; 1999 Mar; 83(4):410-5. PubMed ID: 10210562
[TBL] [Abstract][Full Text] [Related]
9. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Rosen RC; Fitzpatrick JM;
BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
[TBL] [Abstract][Full Text] [Related]
10. [Benign prostatic hyperplasia and its treatment: impact on quality of life and sexual function].
Castro-Díaz D; Díaz-Cuervo H; Pérez M
Actas Urol Esp; 2013 Apr; 37(4):233-41. PubMed ID: 23246106
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction.
Rosen RC; Catania JA; Althof SE; Pollack LM; O'Leary M; Seftel AD; Coon DW
Urology; 2007 May; 69(5):805-9. PubMed ID: 17482908
[TBL] [Abstract][Full Text] [Related]
12. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
[TBL] [Abstract][Full Text] [Related]
13. Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study.
Oelke M; Giuliano F; Baygani SK; Melby T; Sontag A
BJU Int; 2014 Oct; 114(4):568-75. PubMed ID: 24612148
[TBL] [Abstract][Full Text] [Related]
14. [Quality of life assessment of the male with benign prostate hypertrophy].
Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
[TBL] [Abstract][Full Text] [Related]
15. Linguistic adaptation and validation of the Spanish version of the Benign Prostatic Hyperplasia-Patient Impact Measure (BPH-PIM).
Llorente C; Ruiz M; Rejas Gutiérrez J; Esteban M; Villasante F; Hareendran A
Clin Drug Investig; 2006; 26(2):103-12. PubMed ID: 17163240
[TBL] [Abstract][Full Text] [Related]
16. Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a prospective study.
Komiya A; Suzuki H; Awa Y; Egoshi K; Onishi T; Nakatsu H; Ohki T; Mikami K; Sato N; Araki K; Ota S; Naya Y; Ichikawa T
Int J Urol; 2010 Jun; 17(6):555-62. PubMed ID: 20370847
[TBL] [Abstract][Full Text] [Related]
17. [Symptomatic benign prostate hyperplasia affects the quality of life of the patients' wives].
Shao Q; Song J; Liu QJ; Tian Y
Zhonghua Nan Ke Xue; 2010 Feb; 16(2):132-6. PubMed ID: 20369696
[TBL] [Abstract][Full Text] [Related]
18. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
19. Relief of BPO or improvement in quality of life?
Teillac P
Eur Urol; 1998; 34 Suppl 2():3-9. PubMed ID: 9732823
[TBL] [Abstract][Full Text] [Related]
20. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
